Thrasos Therapeutics
https://www.thrasos.com/Overview
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Oct 25, 2012 | Funding round | $35M |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 31, 2015 | Thrasos Therapeutics Closes $21M Series D Funding | Thrasos Therapeutics, a Montreal, Canada-based biotherapeutics company focused on kidney disease, closed $21m in Series D funding. The round was led by BDC Capital and SR One. In conjunction with the funding, Ela Borenstein, a manager partn... |
| Oct 25, 2012 | Thrasos Secures $35M | MONTREAL, QUEBEC, Firm completed a $35M financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI). The round was led by new investor, SR One, with funds coming from the GSK Canada ... |
| Oct 25, 2012 | Thrasos Therapeutics Completes $35M Financing | Thrasos Therapeutics, a Montreal, QC, Canada-based clinical stage, biotherapeutics company focused on the discovery and development of targeted therapies for the prevention and treatment of kidney disease, has completed a $35m financing. Th... |
Reviews 0
FAQ about Thrasos Therapeutics
When was Thrasos Therapeutics founded?
Thrasos Therapeutics was founded in 2003.
How much funding has Thrasos Therapeutics raised?
Thrasos Therapeutics has raised $56M in total across 2 funding rounds.
What funding rounds has Thrasos Therapeutics raised?
Parsers VC lists 2 funding rounds of Thrasos Therapeutics, among them a funding round of $35M on Oct 25, 2012.
What has the press written about Thrasos Therapeutics?
Parsers VC has collected 4 articles mentioning Thrasos Therapeutics, among them “Thrasos Therapeutics Closes $21M Series D Funding” (Mar 31, 2015) and “Thrasos Secures $35M” (Oct 25, 2012).
Is Thrasos Therapeutics still active?
Thrasos Therapeutics is probably closed: its latest activity on Parsers VC dates from Apr 3, 2015.